1. Home
  2. AGRZ vs SILO Comparison

AGRZ vs SILO Comparison

Compare AGRZ & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agroz Inc. Ordinary Shares

AGRZ

Agroz Inc. Ordinary Shares

HOLD

Current Price

$2.93

Market Cap

3.3M

ML Signal

HOLD

Logo Silo Pharma Inc.

SILO

Silo Pharma Inc.

BUY

Current Price

$1.18

Market Cap

3.1M

ML Signal

BUY

Company Overview

Basic Information
Metric
AGRZ
SILO
Founded
2020
2010
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Apparel
Sector
Consumer Staples
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
3.1M
IPO Year
2024
2011

Fundamental Metrics

Financial Performance
Metric
AGRZ
SILO
Price
$2.93
$1.18
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 198.1K
33.5K
Earning Date
11-03-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 57.98
EPS
★ N/A
N/A
Revenue
N/A
★ $72,102.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.15
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.17
$1.10
52 Week High
$5.34
$10.43

Technical Indicators

Market Signals
Indicator
AGRZ
SILO
Relative Strength Index (RSI) 57.34 22.31
Support Level $2.71 $1.10
Resistance Level $3.78 $4.80
Average True Range (ATR) 0.58 0.10
MACD -0.16 0.03
Stochastic Oscillator 7.70 17.07

Price Performance

Historical Comparison
AGRZ
SILO

About AGRZ Agroz Inc. Ordinary Shares

Agroz Inc is a vertically integrated agricultural technology (AgTech) company focused on designing, innovating, developing, building, operating and managing large, commercial-scale, industrial-grade indoor CEA vertical farms using CEA practices. Its mission is to improve food safety, food security, and sustainability for society by creating a reliable, accessible food supply through its AgTech products and services. CEA vertical farming is an agricultural method involving crop cultivation through vertically stacked layers in a controlled indoor environment. CEA practices are defined by growing produce in spaces where environmental conditions can be controlled and manipulated to match the needs of specific plants.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.

Share on Social Networks: